Literature DB >> 8668675

Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique.

B G Müller1, H Leuenberger, T Kissel.   

Abstract

PURPOSE: The purpose of this study was to develop a new method to produce albumin particles in the sub-200-nanometer range with a narrow size distribution and in a controlled and reproducible manner.
METHODS: A new emulsion crosslinking method was developed using ultrasound and static mixing as homogenization steps and a central composite design was used to evaluate the influence of different process parameters on particle size, polydispersity and yield.
RESULTS: Response surface analysis allowed the location of the most important factors. Of all the factors investigated, only the albumin concentration and the aqueous phase volume showed a significant influence on response parameters. Albumin nanospheres with sizes below 200 nm in diameter and very narrow size distributions were obtained in high yields ( > 80%).
CONCLUSIONS: This study describes a new preparation method for albumin nanoparticles which are suitable for future drug targeting studies.

Mesh:

Substances:

Year:  1996        PMID: 8668675     DOI: 10.1023/a:1016064930502

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  3 in total

Review 1.  Albumin microspheres. II: Applications in drug delivery.

Authors:  P K Gupta; C T Hung
Journal:  J Microencapsul       Date:  1989 Oct-Dec       Impact factor: 3.142

2.  Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats.

Authors:  M Roser; D Fischer; T Kissel
Journal:  Eur J Pharm Biopharm       Date:  1998-11       Impact factor: 5.571

3.  Incorporation of water-soluble drugs in albumin microspheres.

Authors:  E Tomlinson; J J Burger
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

  3 in total
  25 in total

1.  Albumin microspheres as carriers for the antiarthritic drug celecoxib.

Authors:  Hetal Thakkar; Rakesh Kumar Sharma; Anil Kumar Mishra; Krishna Chuttani; Rayasa Ramchandra Murthy
Journal:  AAPS PharmSciTech       Date:  2005-09-20       Impact factor: 3.246

2.  Suppression of agglomeration of ciprofloxacin-loaded human serum albumin nanoparticles.

Authors:  P Vijayaraj Kumar; Narendr K Jain
Journal:  AAPS PharmSciTech       Date:  2007-03-02       Impact factor: 3.246

Review 3.  Artificial neural network as a novel method to optimize pharmaceutical formulations.

Authors:  K Takayama; M Fujikawa; T Nagai
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

4.  Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation.

Authors:  M M Stollenwerk; I Pashkunova-Martic; C Kremser; H Talasz; G C Thurner; A A Abdelmoez; E A Wallnöfer; A Helbok; E Neuhauser; N Klammsteiner; L Klimaschewski; E von Guggenberg; E Fröhlich; B Keppler; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-02-20       Impact factor: 4.304

5.  Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization.

Authors:  H Tokumitsu; H Ichikawa; Y Fukumori
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

6.  Redox-sensitive cross-linking enhances albumin nanoparticle function as delivery system for photodynamic cancer therapy.

Authors:  Anna M Molina; Moraima Morales-Cruz; Marimar Benítez; Kiara Berríos; Cindy M Figueroa; Kai Griebenow
Journal:  J Nanomed Nanotechnol       Date:  2015-05-22

7.  Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology.

Authors:  Hasan Kouchakzadeh; Seyed Abbas Shojaosadati; Amir Maghsoudi; Ebrahim Vasheghani Farahani
Journal:  AAPS PharmSciTech       Date:  2010-08-03       Impact factor: 3.246

8.  5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release study.

Authors:  Amir Maghsoudi; Seyed Abbas Shojaosadati; Ebrahim Vasheghani Farahani
Journal:  AAPS PharmSciTech       Date:  2008-10-11       Impact factor: 3.246

9.  Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating.

Authors:  Guilin Wang; Kevin Siggers; Sufeng Zhang; Hongxing Jiang; Zhenghe Xu; Ronald F Zernicke; John Matyas; Hasan Uludağ
Journal:  Pharm Res       Date:  2008-08-15       Impact factor: 4.200

10.  Conjugate Polyplexes with Anti-Invasive Properties and Improved siRNA Delivery In Vivo.

Authors:  Yi Chen; Jing Li; David Oupický
Journal:  Bioconjug Chem       Date:  2018-01-17       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.